Adverse Events by Stages
| . | Stage . | ||||||
|---|---|---|---|---|---|---|---|
| I . | II . | III . | IV CNS− . | IV CNS+ . | B-ALL CNS− . | B-ALL CNS+ . | |
| No. of patients | 49 | 115 | 169 | 12 | 12 | 42 | 14 |
| Early death | 1 | 2 | |||||
| Progression | 1 | 15 | 2 | 3 | 6 | ||
| Death unrelated to tumor | 1 | 5 | 1 | 1 | 3 | ||
| Second malignancy | 1 | 1 | |||||
| . | Stage . | ||||||
|---|---|---|---|---|---|---|---|
| I . | II . | III . | IV CNS− . | IV CNS+ . | B-ALL CNS− . | B-ALL CNS+ . | |
| No. of patients | 49 | 115 | 169 | 12 | 12 | 42 | 14 |
| Early death | 1 | 2 | |||||
| Progression | 1 | 15 | 2 | 3 | 6 | ||
| Death unrelated to tumor | 1 | 5 | 1 | 1 | 3 | ||
| Second malignancy | 1 | 1 | |||||